This is a nationwide cohort study to assess maternal and fetal outcomes following vaccination with a quadrivalent influenza vaccine (QIV) during pregnancy.
Age range
20 Years – 44 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Risk of adverse pregnancy outcomes
Timeframe: from delivery up to 1 year after birth
Risk of vaccine-related adverse events
Timeframe: from delivery up to 1 year after birth
Risk of poor health outcomes in pregnant women
Timeframe: from delivery up to 1 year after birth
Risk of poor health outcomes in neonates
Timeframe: from delivery up to 1 year after birth